Delivery Order SPE2DB22D3011-SPE2DB23FQ2PR
Award Date 8/9/23
Potential Completion Date 8/10/23
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,677.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The contract calls for Amerisourcebergen to provide 2ML pens of the drug to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 18th through the 21st of 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $10,365.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver 2ML pens of DUPIXENT to a location in Conshohocken, Pennsylvania by August 31, 2023 to support Defense Logistics Agency programs. Amerisourcebergen Corporation is the identified parent company for Amerisourcebergen Drug Corporation, the prime contractor performing under this delivery order...
- The Defense Logistics Agency awarded a $10,801 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical product to the DLA by September 8, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
- The Defense Logistics Agency awarded a $13,654.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will deliver this pharmaceutical product to a location in Conshohocken, Pennsylvania by July 28, 2023 in support of DLA's mission to provide medical supplies and logistics support to the Department of Defense. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which...
- The Defense Logistics Agency awarded a $43,565.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver approximately 2,000 pens of the drug to a facility in Conshohocken, Pennsylvania over a one day period in late July 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order from its corporate offices to...
- The Defense Logistics Agency awarded a $29,742 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical products to the DLA by August 9, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
- The Defense Logistics Agency awarded a $35,472.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will provide approximately 2,000 pens of the injectable drug to support DLA's medical supply needs. As the prime, Amerisourcebergen will perform the order itself out of its Conshohocken, Pennsylvania distribution facility. No subcontractors or set aside designations were specified. This award is...
- The Defense Logistics Agency awarded a $32,885.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will deliver this pharmaceutical product to a location in Conshohocken, Pennsylvania by August 18, 2023 to support the Defense Logistics Agency's supply chain needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major...
- The Defense Logistics Agency awarded a $9,390.35 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 28, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA utilizes contracts to procure medical supplies and equipment for the U.S....
- The Defense Logistics Agency awarded a $6,985 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical products to the DLA by August 16, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FQ2PRDelivery Order
The Defense Logistics Agency awarded a $10,044.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately two pens of the drug to fulfill DLA requirements. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location. No major subcontractors or set aside designations were identified. This award draws from DLA's portfolio of pharmaceutical contracts to support the medical readiness of the U.S. armed forces.
Generated 12/22/23, 9:31 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/9/23 |